“…Moreover, HOXA-AS2 acts as a sponge for miR-520c-3p and miR-106a to regulate TGFBR2/RELA and SCN3A, respectively, thereby enhancing tumor progression in BC [ 169 , 170 ]. Additionally, HOXA-AS2 is implicated in the development and progression of various other cancers, including CC [ 171 ], papillary thyroid cancer[ 172 ], type I endometrial carcinoma [ 173 ], NPC [ 174 ], osteosarcoma [ 175 ], NSCLC [ 176 ], bladder cancer (BCa) [ 177 ], and thoracic aortic aneurysm [ 178 ]. In these cases, HOXA-AS2 modulates different miRNA-related pathways, such as miR-509-3p/BTN3A1, miR-15a-5p/HOXA3, miRNA-302c-3p/ZFX, miR-519/HIF-1α/PD-L1, miR-124-3p/E2F3, miR-216a-5p, miR-125b/Smad2, and miR-520d-3p/KIAA1522/IGF2BP3, to promote tumor progression (Table 3 and Fig.…”